Literature DB >> 22294136

[Analytical quality of assays and comparison of procedures for the sweat test].

Thao Nguyen-Khoa1, Jean-Pierre Borgard, Martine Marchand, Dominique Sitruk-Khalfon, Marie-Noëlle Feuillet, Delphine Feldmann, Anne Vassault, Michèle Rota.   

Abstract

Sweat test measuring the chloride ion (Cl(-)) concentration in sweat is a tool for the cystic fibrosis (CF) diagnosis. We evaluated analytical criteria of different available methods and compared them into five hospitals and throught a national quality control program. Sweat tests were performed by stimulation using pilocarpine iontophoresis, sweat collection and measurement of sweat Cl(-) (mmol/L) by titration (colorimetric or coulometric end-point) or by in situ direct potentiometry using a chloride-selective electrode. Indirect determination by sweat conductivity measurement was expressed in mmol/L sodium chloride (NaCl) equivalents (Eq). Linearity range was demonstrated for all measurement procedures in the range 10 to 120 mmol/L. Intra-laboratory coefficients of variation (CVs) were <5% for values between 10 and 100 mmol/L. Inter-laboratory CVs were <3% only for conductivity measurement whatever the range. The comparison of results obtained for a same sweat sample, simultaneously by coulometric and conductivity measurements, demonstrated a first degree linear distribution between 30 to 60 mmol/L Cl(-) allowing us to establish an analytical correspondence table for this range. Thus, calculated values for 30, 40 and 60 mmol/L Cl(-) were respectively 57, 66 and 84 mmol/L NaCl Eq. In conclusion, comparison of methods highlighted that the less the sweat test is automatically controlled, the more the operator influence on results quality is important. Our study supports that sweat test result <50 mmol/L NaCl Eq is unlikely with CF diagnosis in absence of clinical arguments.

Entities:  

Mesh:

Year:  2012        PMID: 22294136     DOI: 10.1684/abc.2011.0650

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  4 in total

1.  Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.

Authors:  Anne Munck; Dominique Delmas; Marie-Pierre Audrézet; Lydie Lemonnier; David Cheillan; Michel Roussey
Journal:  J Med Screen       Date:  2017-04-28       Impact factor: 2.136

2.  Performance Evaluation of a New Coulometric Endpoint Method in Sweat Testing and Its Comparison With Classic Gibson&Cooke and Chloridometer Methods in Cystic Fibrosis.

Authors:  Yasemin Gokdemir; Pinar Vatansever; Bulent Karadag; Tuncay Seyrekel; Ozgur Baykan; Nilay Bas Ikızoglu; Refika Ersu; Fazilet Karakoc; Goncagul Haklar
Journal:  Front Pediatr       Date:  2018-05-22       Impact factor: 3.418

3.  Sweat chloride quantification using capillary electrophoresis.

Authors:  Patricia Dubot; Jing Liang; Jacobé Dubs; Yohann Missiak; Cédric Sarazin; François Couderc; Elizabeth Caussé
Journal:  Pract Lab Med       Date:  2018-12-07

4.  Sweat chloride assay by inductively coupled plasma mass spectrometry: a confirmation test for cystic fibrosis diagnosis.

Authors:  Antonella Marvelli; Beatrice Campi; Gianfranco Mergni; Maria Elisa Di Cicco; Paola Turini; Paolo Scardina; Riccardo Zucchi; Massimo Pifferi; Giovanni Taccetti; Aldo Paolicchi; Giancarlo la Marca; Alessandro Saba
Journal:  Anal Bioanal Chem       Date:  2020-07-21       Impact factor: 4.142

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.